James R. Komorowski
Direttore Tecnico/Scientifico/R&S presso JDS Therapeutics LLC
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michael S. Satow | M | - |
JDS Therapeutics LLC
 JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | 13 anni |
| Alan J. Kirschbaum | M | 78 |
NXXI, Inc.
 NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 26 anni |
| Phillip M. Satow | M | 81 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | 13 anni |
| John H. Gutfreund | M | 80 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 24 anni |
| Michael A. Zeher | M | 76 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 16 anni |
| Frederic Poses | M | 80 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Joseph R. Gregory | M | 70 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Peter C. Mann | M | 65 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 17 anni |
| Bob Johnston | M | 87 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Michael Koby | M | 51 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Richard Scott Pechter | M | 78 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Pam McWilliams | F | - |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 16 anni |
| Martin G. Friedman | M | - |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Michael V. Quinn | M | - |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | 12 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Mark H. Stenberg | M | 66 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 2 anni |
| Warren Cooper | M | 71 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | - |
| Gail Montgomery | F | 71 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 6 anni |
| Howard B. Johnson | M | 64 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 1 anni |
| P. George Benson | M | 77 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 12 anni |
| Marvin Moser | M | 100 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 11 anni |
| Paul S. Intlekofer | M | 56 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 6 anni |
| Dean N. DiMaria | M | 62 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 4 anni |
| John L. Cassis | M | 75 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | 4 anni |
| Robert E. Pollack | M | 83 |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | - |
| Gerard F. Butler | M | - |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | - |
| Michael A. Fink | M | - |
NXXI, Inc.
NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY. | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 26 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- James R. Komorowski
- Contatti personali
